ArticleHeart, lung and vessels2015
Myocardial recovery during mechanical circulatory support: long-term outcome and elective ventricular assist device implantation to promote recovery as a treatment goal.
Article in Heart, lung and vessels, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 36 citations in OpenAlex.
- Predictors of long-term success after successful explantation of continuous flow left ventricular assist device support.Interdisciplinary cardiovascular and thoracic surgery · 2024Article
- Patient-tailored silicone plug for HeartMate 3™ left ventricular assist device explantation.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2024Article
- Cardiological Challenges Related to Long-Term Mechanical Circulatory Support for Advanced Heart Failure in Patients with Chronic Non-Ischemic Cardiomyopathy.Journal of clinical medicine · 2023Review
- Myocardial Recovery.Diagnostics (Basel, Switzerland) · 2023Review
- Editorial: Physiology in extreme conditions: Adaptations and unexpected reactions, Volume II.Frontiers in physiology · 2023Article
- Myocardial recovery evaluation from ventricular assist device in patients with dilated cardiomyopathy.ESC heart failure · 2022Article
- Role of Echocardiography in the Management of Patients with Advanced (Stage D) Heart Failure Related to Nonischemic Cardiomyopathy.Reviews in cardiovascular medicine · 2022Review
- A Scalable Approach to Determine Intracardiac Pressure From Mechanical Circulatory Support Device Signals.IEEE transactions on bio-medical engineering · 2021Article
- The role of ventricular assist device in children.Cardiovascular diagnosis and therapy · 2021Review
- Heart failure in the young: Insights into myocardial recovery with ventricular assist device support.Cardiovascular diagnosis and therapy · 2021Article
- Weaning from ventricular assist device support after recovery from left ventricular failure with or without secondary right ventricular failure.Cardiovascular diagnosis and therapy · 2021Review
- Comparative analysis of cardiac mechano-energetics in isolated hearts supported by pulsatile or rotary blood pumps.Scientific reports · 2019Article
- Leveraging Device-Arterial Coupling to Determine Cardiac and Vascular State.IEEE transactions on bio-medical engineering · 2019Article
- Hurdles to Cardioprotection in the Critically Ill.International journal of molecular sciences · 2019Review
- Left ventricular assist device recovery: does duration of mechanical support matter?Heart failure reviews · 2019Review
- CSI position statement on management of heart failure in India.Indian heart journal · 2018Review
- Mechanical circulatory support device-heart hysteretic interaction can predict left ventricular end diastolic pressure.Science translational medicine · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Even after incomplete myocardial recovery during mechanical circulatory support, long-term survival rates after ventricular assist device (VAD) explantation can be better than those expected after heart transplantation even for patients with chronic non-ischemic cardiomyopathy as the underlying cause for VAD implantation. The elective therapeutic use of ventricular assist devices for heart failure reversal in its early stage is a future goal. It may be possible to achieve it by developing tools to predict heart failure reversibility even before ventricular assist device implantation and increasing the number of weaning candidates by improvement of adjunctive therapies to optimize unloading-promoted recovery. Special attention is focused on the long-term stability of cardiac remission after VAD removal, the clinical relevance unloading-promoted myocardial recovery and on the current knowledge about a potential prediction of myocardial recovery during long-term VAD support already before VAD implantation.
Indexed as
Identifiers
26811834PMC4712031W2413619142What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.